Globus Medical Stock Surges on Strong Q4 Results and Optimistic 2026 Outlook

Globus Medical (GMED) shares jump 9.4% in premarket trading after reporting preliminary Q4 sales of $823.2M, beating analyst estimates, with strong 2026 guidance signaling continued growth momentum.